Gabriella Sozzi
Corporate Officer/Principal at Gensignia Life Sciences, Inc.
Network origin in Gabriella Sozzi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone.
2
| Private Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gabriella Sozzi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Gensignia Ltd. | Founder | ||
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Founder | |
| OKYO PHARMA LIMITED | Biotechnology | Chairman | |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Gensignia IP Ltd. is a professional, scientific, and British technical services company. Part of Gensignia Life Sciences, Inc., the company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| Biovitas Capital Ltd. | Founder | ||
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Miscellaneous Commercial Services | Founder | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Panetta Partners Ltd.
 Panetta Partners Ltd. Financial ConglomeratesFinance Panetta Partners Ltd. is a private equity firm that primarily invests in technology companies. | Financial Conglomerates | Corporate Officer/Principal | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Founder | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Founder | |
| Barrington Capital Group LP | Chief Investment Officer | ||
| SIGA TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Investment Managers | Chief Investment Officer | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 15 |
| United Kingdom | 7 |
| Bermuda | 2 |
Sectoral
| Health Technology | 12 |
| Commercial Services | 3 |
| Finance | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Operational
| Chairman | 13 |
| Founder | 12 |
| Director/Board Member | 7 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Gabriele Cerrone | 22 |
| Mattia Boeri | 1 |
- Stock Market
- Insiders
- Gabriella Sozzi
- Company connections
